| 查看: 570 | 回复: 1 | |||
[交流]
Canadian Journal of Gastroenterology and Hepatology（IF=2.147, 3区）专刊征稿
|
|
各位同仁，Canadian Journal of Gastroenterology and Hepatology（IF=2.147, 中科院分区3区）专刊“NAFLD and its association with metabolic syndrome”目前正在征稿，欢迎大家多多赐稿！如有疑问，敬请留言。 NAFLD and its association with metabolic syndrome Call for Papers Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of liver disorders ranging from simple accumulation of fat (steatosis) to steatohepatitis (NASH), fibrosis, and eventual cirrhosis, which increase the risk of hepatocellular carcinoma (HCC) and may ultimately lead to liver-related death. NAFLD is now rising at an alarming rate and currently becomes the predominant cause of chronic liver disease worldwide. Because of its increasing prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies, NAFLD has emerged as a worldwide health concern and a major challenge, gradually. Although achievements have been made in this field in recent years, knowledge on the development and progression of NAFLD is still incomplete. Substantial evidence demonstrates a strong association between NAFLD and the features of metabolic syndrome, such as obesity, dyslipidemia, hyperglycemia, hypertension, and insulin resistance. However, factors linking NAFLD with metabolic syndrome and the underlying mechanisms of these connections have not been fully elucidated. Thus, enhancing the knowledge on the development and progression of NAFLD could provide further insights into the understanding of the pathogenesis of NAFLD and metabolic syndrome, which may give a reliable basis for new prevention and treatment strategies for these diseases. We invite investigators to contribute original research articles as well as review articles to share the knowledge on NAFLD and the association between NAFLD and metabolic syndrome, with a particular interest in mechanistic insights into these processes. Besides, the insights into prevention and treatment of NAFLD, such as nutritional interventions, are also welcomed. Potential topics include but are not limited to the following: Development of hepatic steatosis Progression from steatosis to more advanced stages of NAFLD (i.e., NASH, liver fibrosis, and cirrhosis) Association between NAFLD and features of metabolic syndrome (i.e., insulin resistance, hyperglycemia, dyslipidemia, and obesity) Prevention and treatment of NAFLD Nutritional intervention of NAFLD Potential role of environmental contaminants in NAFLD Authors can submit their manuscripts through the Manuscript Tracking System at https://mts.hindawi.com/submit/journals/cjgh/hepatology/nams/. Submission Deadline Friday, 3 November 2017 Publication Date March 2018 Papers are published upon acceptance, regardless of the Special Issue publication date. Lead Guest Editor Zi-Feng Zhang, Jiangsu Normal University, Xuzhou, China Guest Editors Saurabh Chatterjee, University of South Carolina, Columbia, USA Lei Chen, Fujian Agriculture and Forestry University, Fuzhou, China Kezhong Zhang, Wayne State University, Detroit, USA Amedeo Lonardo, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy |
回复此楼» 猜你喜欢
2025冷门绝学什么时候出结果
已经有3人回复
-
天津工业大学郑柳春团队欢迎化学化工、高分子化学或有机合成方向的博士生和硕士生加入
已经有4人回复
-
康复大学泰山学者周祺惠团队招收博士研究生
已经有6人回复
-
AI论文写作工具：是科研加速器还是学术作弊器？
已经有3人回复
-
孩子确诊有中度注意力缺陷
已经有6人回复
-
2026博士申请-功能高分子，水凝胶方向
已经有6人回复
-
论文投稿，期刊推荐
已经有4人回复
-
硕士和导师闹得不愉快
已经有13人回复
-
请问2026国家基金面上项目会启动申2停1吗
已经有5人回复
-
同一篇文章，用不同账号投稿对编辑决定是否送审有没有影响？
已经有3人回复
2楼2017-06-29 22:56:04